Realbotix Corp., through its subsidiary Realbotix LLC, officially launched the Echo humanoid robot platform on October 26, 2026. The Echo line includes two models: the Echo Tabletop, priced at $11,950, and the Echo Full Body, priced at $59,950. These robots are designed to enhance education, wellness, and social engagement by providing lifelike expressions and AI-driven interactions.
Realbotix announced an initial production run of 225 Echo Tabletop units and 25 Echo Full Body units, with deliveries anticipated in the second half of 2027. The robots are manufactured in the United States and incorporate patented AI and robotics technologies to enable realistic motion and vision for improved human interaction.
This launch coincides with Onconetix’s pending acquisition of Realbotix LLC, which was announced in February 2026. The acquisition, subject to shareholder and regulatory approvals, will combine biotechnology and advanced robotics under Onconetix’s corporate umbrella, aiming to expand into new markets.
Realbotix’s Echo robots represent an advancement in humanoid robotics, targeting sectors where social engagement and wellness are critical. By integrating AI capabilities with human-like interaction, these robots have potential applications in educational and wellness programs.